GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $0 | -100.0% | 19 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | -50.0% | 19 | -52.5% | 0.00% | – |
Q1 2020 | $2,000 | -50.0% | 40 | -16.7% | 0.00% | – |
Q4 2019 | $4,000 | +100.0% | 48 | +20.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | -84.6% | 40 | -87.3% | 0.00% | -100.0% |
Q4 2018 | $13,000 | -99.8% | 315 | +129.9% | 0.00% | 0.0% |
Q2 2018 | $6,193,000 | +19253.1% | 137 | -79.0% | 0.00% | -66.7% |
Q1 2018 | $32,000 | +700.0% | 653 | +573.2% | 0.00% | – |
Q4 2017 | $4,000 | +100.0% | 97 | +59.0% | 0.00% | – |
Q3 2017 | $2,000 | -66.7% | 61 | -70.2% | 0.00% | -100.0% |
Q2 2017 | $6,000 | +20.0% | 205 | +40.4% | 0.00% | – |
Q1 2017 | $5,000 | -44.4% | 146 | -77.0% | 0.00% | -100.0% |
Q4 2016 | $9,000 | – | 636 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
Grace Capital | 131,549 | $5,697,000 | 3.60% |
Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |